Back to Results
First PageMeta Content
Piperazines / Atypical antipsychotics / Clozapine / Drug rehabilitation / Desmethylclozapine / Agranulocytosis / Methadone / Novartis / Generic drug / Chemistry / Organochlorides / Organic chemistry


CLOZAPINE RECOMMENDATIONS TO PSYCHIATRISTS FOR CONVERSION OF BRAND NAME CLOZARIL TO GENERIC CLOZAPINE 1. INTENT These recommendations are not intended to be construed or to serve
Add to Reading List

Document Date: 2010-09-14 09:49:00

Open Document

File Size: 39,98 KB

Share Result on Facebook

Company

Mylan Laboratories Inc. / Novartis / CBC / Missouri Medicaid Bulletin / Ivax Corporation / Clozaril / /

Country

United States / /

Event

FDA Phase / /

IndustryTerm

technology advance / generic products / /

MedicalCondition

insomnia / severe mental illness / such an illness / Agranulocytosis / chronic relapsing condition / /

MedicalTreatment

Counseling / /

OperatingSystem

Dos / /

Organization

Drug Prior Authorization Unit / Food and Drug Administration / /

Person

D. Rakhshanda Hassan / M.D. Steve Stoner / D. Roger Somni / M.D. Shashi Polavarapu / D. Susan McCann / D.O. Joseph Parks / M.D. Usha Manusmare / D. Lori DeRosear / John Csernansky / Eleatha Surratt / D. David Vlach / M.D. Dan Dugan / M.D. John Newcomer / M.D. Enrique Dos Santos / /

/

Position

psychiatrist / prescribing physician / pharmacist / physician / /

Product

CLOZAPINE / CLOZARIL / /

ProgrammingLanguage

C / /

ProvinceOrState

Missouri / /

SocialTag